Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
When To Choose A Benchmark Over A Strategic Index explains decision points for selecting benchmarks based on goals, cost, and risk tolerance.
25,499 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Gas prices have climbed back above the $4 per gallon mark, driven by geopolitical tensions and supply concerns. This ...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...
Apple’s latest strategy signals a shift from pure premium to share growth. This article explores how pricing, service...
Constellation Energy plunged today after a mix of macro moves and strategic shifts. This guide breaks down the factor...
Southwest Airlines CEO Bob Jordan is taking a bold step to reclaim time for real work by blocking Wednesday through F...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
As AI data centers expand, SanDisk Corporation is drawing new investor interest. The stock has moved higher on expect...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
SpaceX's leadership reshapes the space economy. This article highlights three powerful space stocks that could benefi...
Tech stocks can swing fast. When shares intel have plummeted, investors must separate noise from fundamentals. This g...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...